K.-D. Schulz

Luteinizing hormone-releasing hormone agonist triptorelin antagonizes signal transduction and mitogenic activity of epidermal growth factor in human ovarian and endometrial cancer cell lines

Günter Emons, Veronika Müller, Olaf Ortmann et al. · International Journal of Oncology · 1996 · 64 citations

Signal Transduction Mechanisms, Epidermal Growth Factor, Signal Transduction +15

Morbidity, Mortality, and Albuminuria in Type 2 Diabetic Patients: a Three‐year Prospective Study of a Random Cohort in General Practice

H. Stiegler, Eberhard Standl, K.-D. Schulz et al. · Diabetic Medicine · 1992 · 59 citations

Expression of luteinizing hormone releasing hormone and its mRNA in human endometrial cancer cell lines.

G Irmer, Claudia Bürger, Olaf Ortmann et al. · The Journal of Clinical Endocrinology & Metabolism · 1994 · 50 citations

Biochemistry, Hormonal Receptor, Gynecology +9

Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study

Ute Albert, Michael Koller, I. Kopp et al. · Breast Cancer Research and Treatment · 2006 · 49 citations

Late Side Effects, Breast Oncology, Medicine +8

Primary breast cancer therapy in six regions of Germany

Jutta Engel, Gabriele Nagel, Eun‐Kyoung Breuer et al. · European Journal of Cancer · 2002 · 46 citations

Breast Oncology, Medicine, Cancer Management +3